Alok Deshane, MD

MSKCC

New York, NY

Disclosures:

Presentations

Sep 29

200 - TP53 Mutations and Outcomes after Radiotherapy in Mantle Cell Lymphoma

10:55am - 11:05am PT

Sep 30

3420 - When Less Is More: Reducing the Administration of Inappropriate Radiotherapy to Patients with Very Poor Prognosis

Hall F

02:30pm - 03:45pm PT